Australia's most trusted
source of pharma news
Thursday, 11 June 2026
Thursday, 11 June 2026
Subscribe
Login
Pharma boss breaks Aussie house record
This pharma boss and his wife have broken an Australian house price record by paying $136.1 million for a Melbourne mansion and neighbouring apartment block.
US biotech lands T cell drug in Aust
US biotech enters the Australian market with the TGA approving the first T cell therapy for solid tumour cancer
TODAY
Pharma drops $39M on meetings
The latest transparency reports show the pharmaceutical industry spent tens of millions of dollars in third-party support
TODAY
Is this pharma's toughest job?
More is being asked of these pharma professionals than ever before in an increasingly complex landscape
10 June
On a roll: Arrotex signs new deal
Local giant seizes the ANZ rights to an innovative anti-seizure drug, signing a deal with a Korean pharma
10 June
Mega-drug faces revenue 'wipeout'
Analysts are now branding loss of exclusivity for this drug one of the biggest patent cliff falls in pharma history
9 June
Cloud over PBAC drug after 27 deaths
Patient deaths in a trial have raised safety concerns about a drug that just hit the ARTG and is on the July PBAC agenda
9 June
Latest Jobs
Account ManagerClinical Account ManagerTerritory ManagerSenior Medical Science LiaisonWeb ProducerPharmaceutical Sales RepresentativeSenior Quality Assurance ManagerQuality Control Systems Specialist34 more...
Pharma in Focus Jobs
Marketing & Communications (1)
Sales & Customer Relations (22)
- Account Manager - Sydney
- Clinical Account Manager - Melbourne
- Territory Manager - Sydney
- Pharmaceutical Sales Representative - Brisbane
- Customer Service Representative - Macquarie Park
- Customer Service Representative - Macquarie Park
- Senior Director, Business Development - Clinical Research - Tokyo, Japan
- Senior Director, Business Development - Clinical Research (Tokyo Based) - Tokyo, Japan
- Equipment Sales Specialist - Dental - Sydney
- Territory Manager - Melbourne
- Key Account Manager - Melbourne
- Senior Group Financial Accountant - Victoria
- Strategic Sales Director ANZ, Digital Health - Sydney
- Strategic Sales Director ANZ, Digital Health - Melbourne
- Sales Manager / Territory Manager - Christchurch
- Business Development Manager – Health Tech - Melbourne
- Business Development Manager – Health Tech - Brisbane
- GP Representative - Geelong
- Business Development Manager, Health Tech - Sydney
- Territory Manager - Gold Coast
- Sales Director - Sydney
- Medical Sales Representative - Sydney
Access & Reimbursement (1)
Clinical & Medical, R&D (10)
- Clinical Account Manager - Melbourne
- Senior Medical Science Liaison - Sydney
- Associate Director, Clinical Operations (Japan) - Tokyo, Japan
- Senior Director, Business Development - Clinical Research - Tokyo, Japan
- Senior Director, Business Development - Clinical Research (Tokyo Based) - Tokyo, Japan
- Clinical Trial Investigator - Melbourne
- Senior Medical Manager - Melbourne
- Clinical Trial Start Up Specialist - Melbourne
- Medical Sales Representative - Sydney
- Clinical Trial Nurse Unit Manager - Melbourne
Regulatory, Pharmacovigilance & QA (4)
- Senior Quality Assurance Manager - Sydney
- Quality Control Systems Specialist - Tullamarine
- Director - Regulatory Affairs - Melbourne
- Country Head, Regulatory Affairs, ANZ - Melbourne
Executive Roles (9)
- Associate Director / Senior Manager, Market Access (ANZ) - Melbourne
- Associate Director, Clinical Operations (Japan) - Tokyo, Japan
- Senior Director, Business Development - Clinical Research - Tokyo, Japan
- Senior Director, Business Development - Clinical Research (Tokyo Based) - Tokyo, Japan
- Director - Regulatory Affairs - Melbourne
- Strategic Sales Director ANZ, Digital Health - Sydney
- Strategic Sales Director ANZ, Digital Health - Melbourne
- Director of Operations, HealthTech - Melbourne
- Sales Director - Sydney
Other (8)
PBAC Chair lays it all on the table
In a free-flowing conversation at ARCS, Robyn Ward offered frank views on a wide range of topics, including HTA reform
TODAY
Industry body unveils name change
After 40 years, a new identity that better reflects members' professional standing and the organisation's expanding role
TODAY
Record turnout for ARCS conference
Pharma professionals have descended on Sydney's International Convention Centre for the 2026 ARCS conference which kicked off today
10 June
GSK in $15B 'multiblockbuster' deal
Deal comes with two potential best-in-class assets that could launch this year if FDA approval comes through
10 June
6-year-old takes PBS plea to Butler
Heartstrings campaign puts pressure on the Health Minister to expand the listing of this blockbuster to children
10 June
Push for new PBS prescribers
New report commissioned by the Pharmacy Guild claims $1B in direct savings to the health system is ripe for picking
9 June
Who made the King's Honours List?
Well known to industry, this inspirational patient advocate has been recognised for her tireless work and bold vision
9 June
Two first generics win TGA ticks
Exclusivity challenges loom following the arrival of generic competition stoking a familiar rivalry between two companies
9 June Approvals Action
Who's flexing the hottest pipeline?
There's a new Number 1 on this year's Pharmaceutical Invention Index with a long-standing champ relegated to second spot
5 June
Aussie jobs cut with grim warning
As industry faces headwinds this Big Pharma is downsizing for its 'future sustainability' plus other popular stories this week
5 June Your Week in 5 Minutes
Anxious Aussies hit Google for meds
Times are tough and Australians are conducting almost a million Google searches a month to treat their anxiety
5 June
Lilly showcases Alzheimer's data
Evidence and real-world data presented at Aussie forum that should build confidence in earlier, more accurate diagnoses
5 June
A PBAC funding model that works?
New blueprint proposes removal of lowest cost comparator to boost both innovative medicine launches and biosim uptake
5 June
Pharma winners and losers in Q1
Industry saw good sales growth in the first quarter of this year, with some soaring to new heights while others went backwards
4 June